Ligand Pharmaceuticals Seeks Unrestricted Release of Cranbury Facility

Summary

Ligand Pharmaceuticals has submitted a proposal to the Nuclear Regulatory Commission for an unrestricted release of its facility in Cranbury, NJ, following the completion of an environmental assessment and finding of no significant impact for its byproduct materials license.

Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Energy & environment · 8/25/2026

NRC Issues Environmental Assessment and Finding of No Significant Impact for SMR-300 Plant

The U.S. Nuclear Regulatory Commission has approved an environmental assessment and finding of no significant impact for SMR, LLC's request to construct support of excavation walls during the excavation of the proposed SMR-300 plant at the Palisades Energy Center in Michigan.

Read summary →

Energy & environment · 9/29/2026

NRC Publishes Biweekly Notice on Facility Operating Licenses and Combined Licenses

The U.S. Nuclear Regulatory Commission is publishing a biweekly notice on amendments and proposed amendments to facility operating licenses and combined licenses that do not involve significant hazards considerations, as required by the Atomic Energy Act of 1954.

Read summary →

Energy & environment · 9/11/2026

Dominion Energy Virginia Seeks Renewal of North Anna Early Site Permit

The U.S. Nuclear Regulatory Commission is considering a renewal application for the Early Site Permit No. ESP-003 at the North Anna site in Virginia, which would extend the permit's expiration date by 20 years.

Read summary →

Energy & environment · 9/11/2026

NRC Seeks Public Comment on Renewal of OMB Approval for NRC Form 212

The U.S. Nuclear Regulatory Commission (NRC) is seeking public comment on the renewal of Office of Management and Budget (OMB) approval for NRC Form 212, a collection of information related to qualifications investigation professional, technical, and administrative positions.

Read summary →

Energy & environment · 9/8/2026

NRC to Consider Amendment Request for Shearon Harris Nuclear Power Plant, Unit 1

The U.S. Nuclear Regulatory Commission (NRC) is considering approval of an amendment request for the Shearon Harris Nuclear Power Plant, Unit 1, which proposes to determine that it involves no significant hazards consideration (NSHC). The request contains sensitive unclassified non-safeguards information (SUNSI), prompting the NRC to issue procedures for accessing this information.

Read summary →

Energy & environment · 9/1/2026

NRC Publishes Biweekly Notice on Amendments to Operating Licenses

The U.S. Nuclear Regulatory Commission (NRC) is publishing a biweekly notice regarding amendments to operating licenses, as required by the Atomic Energy Act of 1954, and grants the authority to issue immediate amendments with no significant hazards consideration.

Read summary →